Skip to content
No results
  • Newsletter
Bokern – Intelligence & Technology
Bokern – Intelligence & Technology
  • Artificial Intelligence

Medical AI reaches $15 billion valuation, but clinical effectiveness remains in question

Medical AI reaches $15 billion valuation, but clinical effectiveness remains in question

A startup combining AI and medical literature OpenEvidence uses artificial intelligence to research and synthesize medical knowledge, providing answers supported by expert references. Following a $250 million funding round in September, the company was valued at $15 billion. The platform…

  • Boker Nielson
  • October 21, 2026
  • Artificial Intelligence

Demis Hassabis predicts general artificial intelligence within two years and accelerates AI-driven drug discovery

Demis Hassabis predicts general artificial intelligence within two years and accelerates AI-driven drug discovery

Demis Hassabis, co-founder of Google DeepMind and winner of the 2024 Nobel Prize in Chemistry, has revised his forecast for the arrival of artificial intelligence with human-like cognitive abilities from three to five years to just two to three years,…

  • Boker Nielson
  • October 21, 2026
  • Artificial Intelligence

Tivita launches Tom, an AI assistant that writes medical records during consultations

Tivita launches Tom, an AI assistant that writes medical records during consultations

Brazilian healthtech company Tivita has launched Tom, a digital agent powered by artificial intelligence that records conversations between doctors and patients and generates a draft medical report. The doctor reviews and signs off on the text, while the tool is…

  • Boker Nielson
  • October 6, 2026
  • Artificial Intelligence

When AI doesn’t know: the importance of recognizing limits and avoiding hallucinations

When AI doesn’t know: the importance of recognizing limits and avoiding hallucinations

The problem of hallucinations Ask an artificial intelligence (AI) assistant a question, and it will almost always provide an answer, even if it doesn’t know the correct response. This phenomenon is known as hallucination and represents one of the most…

  • Boker Nielson
  • October 2, 2026
  • Artificial Intelligence

Brazil can profit from AI without creating its own ChatGPT

Brazil can profit from AI without creating its own ChatGPT

Brazil’s Artificial Intelligence Plan allocates around R$23 billion between 2024 and 2028, distributed across infrastructure, training, public services, business innovation, and governance. The budget isn’t limited to building a chatbot, suggesting a broader strategy for technology adoption. Infrastructure and Portuguese-language…

  • Boker Nielson
  • October 1, 2026
  • Artificial Intelligence

Feed Medic: AI platform helps doctors create digital content under full supervision

Feed Medic: AI platform helps doctors create digital content under full supervision

Feed Medic, founded by Rafael Freitas and Lucas Vieira, offers an AI-powered solution that enables healthcare professionals to generate Instagram posts, captions, stories, and reels while adhering to the Federal Council of Medicine’s (CFM) guidelines. The idea emerged from the…

  • Boker Nielson
  • September 25, 2026
  • Artificial Intelligence

The Rare Knowledge Campaign combines AI, Wikipedia, and healthcare to improve access to information on rare diseases

The Rare Knowledge Campaign combines AI, Wikipedia, and healthcare to improve access to information on rare diseases

Raras Health and Wikimedia Brasil have launched the Rare Knowledge initiative, which aims to improve access to information on over 10,000 rare diseases. The initiative combines an AI assistant on WhatsApp, scientific articles, protocols from Brazil’s Unified Health System, and…

  • Boker Nielson
  • September 25, 2026
  • Artificial Intelligence

Brazilian companies’ digital maturity still leaves AI in the background

Brazilian companies’ digital maturity still leaves AI in the background

The latest edition of the Digital Mindset Panorama, a survey by consultancy Brivia Group that assesses the digital maturity of companies in Brazil, reveals that despite the constant presence of artificial intelligence in board meetings and CEO speeches, the AI…

  • Boker Nielson
  • September 22, 2026
  • Artificial Intelligence

Ammonix bets on specialized AI that acknowledges its limitations after Cortex’s billion-dollar sale

Ammonix bets on specialized AI that acknowledges its limitations after Cortex’s billion-dollar sale

Following the sale of Cortex to Boston Scientific for up to $289 million, scientist Peter Ruppersberg launched Ammonix, a Swiss AI startup focused on compact models trained with specific data. Founded in spring 2025 in Blonay, a Swiss town on…

  • Boker Nielson
  • September 21, 2026
  • Artificial Intelligence

Anthropic opens biology lab in San Francisco Bay, advancing pharmaceutical research

Anthropic opens biology lab in San Francisco Bay, advancing pharmaceutical research

Anthropic, the company behind AI model Claude, has opened a physical biology lab in the San Francisco Bay area of the United States. Known as a wet lab, the facility is designed for hands-on experiments, complementing the company’s existing computational…

  • Boker Nielson
  • September 20, 2026
Next

Trending now

Data preparation is becoming a bottleneck for AI expansion in businesses
Norway Considers Ban on Camera-Enabled Wearables Over Privacy Fears
U.S. military disables ad tracking on service devices to protect troops from location-based attacks
OpenAI Confirms Wiki Takeover, Pledges New Disclosure Framework Amid Growing Misalignment Concerns

Copyright © 2026 - Bokern